Genetic susceptibility and class III complement genes

Systemic Lupus Erythematosus, Fourth Edition

Volumn , Issue , 2004, Pages 153-172

  Atkinson, John P ^a   Schneider, Peter M ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35348880399     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012433901-9/50008-9     Document Type: Chapter

References (163)

1. M.J. Walport, K.A. Davies, B.J. Morley and M. Botto (1997) Complement deficiency and autoimmunity. Ann. N.Y. Acad. Sci. 815 267-281.
2. A.G. Sjoholm (1991) Inherited complement deficiency states and disease. Complement Inflamm. 8 341-346.
3. M.C. Pickering, M. Botto, P.R. Taylor, P.J. Lachmann and M.J. Walport (2001) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76 227-322.
4. K. Tokunaga, G. Saueracker and P.H. Kay (1988) Extensive deletions and insertions in different MHC supratypes detected by pulsed field gel electrophoresis. J. Exp. Med. 168 933.
5. F.C. Arnett and J.M. Moulds (1991) HLA class III molecules and autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 9 289.
6. F.T. Christiansen, W.J. Zhang and M. Griffiths (1991) MHC encoded complement deficiency, ancestral haplotypes and SLE: C4 deficiency explains some but not all of the influence of the MHC. J. Rheumatol. 18 1350.
7. Y.C. Ng and J.M. Walport (1988) Immunogenetics of SLE and primary Sjogrens' syndrome. Baillieres Clin. Rheumatol. 2 623.
8. J.A. Schifferli and D.K. Peters (1983) Complement, the immune-complex lattice and the pathophysiology of complement-deficiency syndromes. Lancet 2 957-959.
9. J.P. Atkinson (1986) Complement activation and complement receptors in systemic lupus erythematosus. Springer Semin. Immunopathol. 9 179-194.
10. P.J. Lachmann and M.J. Walport (1987) Deficiency of the effector mechanisms of the immune response and autoimmunity. D. Evered, J. Whelan (Eds) Autoimmunity and Autoimmune Disease New York: Wiley 129.
11. M.E. Medof (1988) Complement-dependent maintenance of immune complex solubility. K. Rother, G.O. Till (Eds) The Complement System Berlin: Springer-Verlag 418-443.
12. J.P. Atkinson (1988) Complement deficiency: Predisposing factor to autoimmune syndromes. Am. J. Med. 85 45-47.
13. J.P. Atkinson (1992) Immune complexes and the role of complement. E.C. LeRoy (Eds) Systemic Vasculitis New York: Dekker 525-546.
14. J.A. Schifferli and R.P. Taylor (1989) Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35 993-1003.
15. A.P. Prodeus, S. Goerg, L.M. Shen, O. Pozdnyakova, L. Chu, E.M. Alicot, C.C. Goodnow and M.C. Carroll (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9 721-731.
16. A.J. Cutler, R.J. Cornall, H. Ferry, A.P. Manderson, M. Botto and M.J. Walport (2001) Intact B cell tolerance in the absence of the first component of the classical complement pathway. Eur. J. Immunol. 31 2087-2093.
17. J.S. Navratil and J.M. Ahearn (2000) Apoptosis and autoimmunity: Complement deficiency and systemic lupus erythematosus revisited. Curr. Rheumat. Rep. 2 32-38.
18. K.E. Sullivan (1998) Complement deficiency and autoimmunity. Curr. Opin. Pediatr. 10 600-606.
19. R.D. Campbell, S.K.A. Law and K.B.M. Reid (1988) Structure, organization and regulation of the complement genes. Annu. Rev. Immunol. 6 161.
20. J.P. Atkinson (1989) The complement system. H. Eisen (Eds) General Immunology Philadelphia: Lippincott 147-166.
21. A.C. Chan, D.R. Karp, D.C. Shreffler and J.P. Atkinson (1984) The twenty faces of the fourth component of complement (C4). Immunol. Today 5 200-203.
22. A.C. Chan and J.P. Atkinson (1985) Oligosaccharide structure of human C4. J. Immunol. 134 1790-1798.
23. G. Hortin, A.C. Chan, K.F. Fok, A.W. Strauss and J.P. Atkinson (1986) Sequence analysis of the C-terminus of the α-chain of the fourth component of human complement: Identification of the site of its extracellular cleavage. J. Biol. Chem. 261 9065-9069.
24. G.L. Hortin, T.C. Farries, J.P. Graham and J.P. Atkinson (1989) Sulfation of tyrosine residues increases activity of the fourth component of complement. Proc. Natl. Acad. Sci. USA 86 1338-1342.
25. A.C. Chan, K.R. Mitchell, T.W. Munns, D.R. Karp and J.P. Atkinson (1983) Identification and partial characterization of a novel form of the fourth component of human complement: Evidence that the secreted form is different from the major plasma form. Proc. Natl. Acad. Sci. USA 80 268-272.
26. D.M. Lublin, M.K. Liszewski, T.W. Post, M.A. Arce, M.M. Le Beau and M.B. Rebentisch (1988) Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP): Evidence for inclusion in the multi-gene family of complement-regulatory proteins. J. Exp. Med. 168 181-194.
27. B.F. Tack (1983) The beta-cys-gamma-glu thioester bond in human C3, C4, and alpha2-macroglobulin. Springer Semin. Immunopathol. 6 259.
28. S.K. Law (1983) Non-enzymic activation of the covalent binding reaction of the complement protein. Biochem. J. 211 381.
29. G.D. Ross, J.A. Cain and P.J. Lachmann (1985) Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J. Immunol. 134 3307-3315.
30. J.M. Ahearn and D.T. Fearon (1989) Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46 183-219.
31. D. Hourcade, V.M. Holers and J.P. Atkinson (1989) The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45 381-416.
32. K.T. Belt, M.C. Carroll and R.R. Porter (1984) The structural basis of the multiple forms of human complement component C4. Cell 36 907.
33. C.Y. Yu, K.T. Belt and C.M. Giles (1986) Structural basis of the polymorphism of human complement component C4A and C4B: Gene size, reactivity and antigenicity. EMBO J. 5 2873.
34. C.Y. Yu, R.D. Campbell and R.R. Porter (1988) A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes. Immunogenetics 27 399.
35. M.C. Carroll, D.M. Fathallah, L. Bergamaschini, E. Alicot and D.E. Isenman (1990) Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. Proc. Natl. Acad. Sci. USA 87 6868.
36. G. Mauff, C.A. Alper, R. Dawkins, G. Doxiadis, C.M. Giles, G. Hauptmann, C. Rittner and P.M. Schneider (1990) C4 nomenclature statement. Complement Inflamm. 7 261-268.
37. G. Mauff, M. Brenden and M. Braun-Stilwell (1990) Relative electrophoretic migration distances for the classification of C4 allotypes. Complement Inflamm 7 277-281.
38. K.T. Belt, C.Y. Yu, M.C. Carroll and R.R. Porter (1985) Polymorphism of human complement component C4. Immunogenetics 21 173-180.
39. M.J. Anderson, C.M. Milner, R.G. Cotton and R.D. Campbell (1992) The coding sequence of the hemolytically inactive C4A6 allotype of human complement C4 reveals that a single arginine to tryptophane substitution at B-chain residue 458 is the likely cause of the defect. J. Immunol. 148 2795.
40. A.W. Dangel, A.R. Mendoza, B.J. Baker, C.M. Daniel, M.C. Carroll, L.C. Wu and C.Y. Yu (1994) The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific patterns among old world primates. Immunogenetics 40 425.
41. X. Chu, C. Rittner and P.M. Schneider (1995) Length polymorphism of the human complement component C4 gene is due to an ancient retroviral integration. Exp. Clin. Immunogenet. 12 74.
42. P.M. Schneider, K. Witzel-Schlomp, C. Rittner and L. Zhang (2001) The endogenous retroviral insertion in the human complement C4 gene modulates the expression of homologous genes by antisense inhibition. Immunogenetics 53 1-9.
43. M. Steuer, G. Mauff and C. Adam (1989) An estimate on the frequency of duplicated haplotypes and silent alleles of human C4 protein polymorphism. Investigations in healthy Caucasoid families. Tissue Antigens 33 501.
44. J. Partanen and R.D. Campbell (1989) Restriction fragment analysis of non-deleted complement C4 null genes suggests point mutations in C4A null alleles but geneconversions in C4B null alleles. Immunogenetics 30 520.
45. L. Braun, P.M. Schneider and C.G. Giles (1990) Null alleles of human complement. Evidence for pseudogenes at the C4A locus and gene conversion at the C4B locus. J. Exp. Med. 171 129-140.
46. M.C. Carroll, A. Palsdittir and K.T. Belt (1985) Deletion of complement c4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J. 4 2547.
47. P.M. Schneider, M.C. Carroll and C.A. Alper (1986) Polymorphism of the human complement C4 and steroid 21-hydroxylase genes: Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J. Clin. Invest. 78 650.
48. C.Y. Yu (1998) Molecular genetics of the human MHC complement gene cluster. Exp. Clin. Immunogenet. 15 213-230.
49. Z. Yang, A.R. Mendoza, T.R. Welch, W.B. Zipf and C.Y. Yu (1999) Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module): A mechanism for gene deletions and disease associations. J. Biol. Chem. 274 12147-12156.
50. C.A. Blanchong, B. Zhou, K.L. Rupert, E.K. Chung, K.N. Jones, J.F. Sotos, W.B. Zipf, R.M. Rennebohm and C.Y. Yu (2000) Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J. Exp. Med. 191 2183-2196.
51. P.M. Schneider (1990) C4 DNA RFLP reference typing report. Complement Inflamm. 7 218.
52. G. Barba, C. Rittner and P.M. Schneider (1993) Genetic basis of human complement C4A deficiency: Detection of a point mutation leading to nonexpression. J. Clin. Invest. 91 1681.
53. G.N. Fredrikson, B. Gullstrand, P.M. Schneider, K. Witzel-Schlomp, A.G. Sjoholm, C.A. Alper, Z. Awdeh and L. Truedsson (1998) Characterization of non-expressed C4 genes in a case of complete C4 deficiency: Identification of a novel point mutation leading to a premature stop codon. Hum. Immunol. 59 713-719.
54. M.L. Lokki, A. Circolo, P. Ahokas, K.L. Rupert, C.Y. Yu and H.R. Colten (1999) Deficiency of human complement protein C4 due to identical frameshift mutations in the C4A and C4B genes. J. Immunol. 162 3687-3693.
55. K.L. Rupert, J.M. Moulds, Y. Yang, F.C. Arnett, R.W. Warren, J.D. Reveille, B.L. Myones, C.A. Blanchong and C.Y. Yu (2002) The molecular basis of complete complement C4A and C4B deficiencies in a systemic lupus erythematosus patient with homozygous C4A and C4B mutant genes. J. Immunol. 169 1570-1578.
56. K.M. O'Neil (2000) Complement deficiency. Clin. Rev. Allergy Immunol. 19 83-108.
57. T.R. Welch and M. Frenzke (2001) Glomerulonephritis associated with deficiencies and polymorphisms of complement components encoded in the class III region of the MHC. Front. Biosci. 6 D898-D903.
58. S.K. Law, A.W. Dodds and R.R. Porter (1984) A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. EMBO J 3 1819.
59. D.E. Isenman and J.R. Young (1984) The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J. Immunol. 132 3019-3027.
60. J.A. Schifferli, G. Steiger and J. Paccaud (1986) Difference in the biological properties of the two forms of the fourth component of human complement. Clin. Exp. Immunol. 63 473.
61. A.W. Dodds, X.D. Ren, A.C. Willis and S.K. Law (1996) The reaction mechanism of the internal thioester in the human complement component C4. Nature 379 177.
62. O. Finco, S. Li, M. Cuccia, F.S. Rosen and M.C. Carroll (1992) Structural differences between the two human isotypes affect the humoral immune response. J. Exp. Med. 175 537.
63. P.A. Gatenby, J.E. Barbosa and P.J. Lachman (1990) Differences between C4A and C4B in the handling of immune complexes: The enhancement of CR1 binding is more important than the inhibition of immunoprecipitation. Clin. Exp. Immunol. 79 158.
64. J.M. Moulds, F.C. Arnett and C.G. Giles (1990) A novel immunoassay for the quantitation of human C4 gene products. Complement Inflamm. 7 95.
65. J.M. Moulds, N.B. Warner and F.C. Arnett (1991) Quantitative and antigenic differences in complement component C4 between American Blacks and Whites. Complement Inflamm. 8 281.
66. J.M. Moulds, N.B. Warner and F.C. Arnett (1994) Complement components C4A and C4B levels in systemic lupus erythematosus: Quantitation in relation to C4 null status and disease activity. J. Rheumatol. 21 577.
67. J. Kulics, A. Circolo, R.C. Strunk and H.R. Colten (1994) Regulation of synthesis of complement protein C4 in human fibroblasts: Cell- and gene-specific effects of cytokines and lipopolysaccharide. Immunology 82 509-515.
68. R.D. Campbell (1987) Molecular genetics of C2 and Factor B. Br. Med. Bull. 43 37.
69. P.M. Schneider and C. Rittner (1997) Complement genetics. A.W. Dodds, B. Sim (Eds) Complement: A Practical Approach Oxford: Oxford Univ. Press 165-199.
70. C.J. Jaffe, J.P. Atkinson and M.M. Frank (1976) The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man. J. Clin. Invest. 58 942-949.
71. A.H.L. Fielder, M.J. Walport and J.R. Batchelor (1983) Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: Importance of null alleles of C4A and 4B in determining disease susceptibility. Br. Med. J. 286 425.
72. F.T. Christiansen, G. Uko and R.L. Dawkins (1982) Complement allotyping in systemic lupus erythematosus: Association with C4A null. R.L. Dawkins (Eds) Immunogenetics in Rheumatology Amsterdam: Excerpta Medica 229-234.
73. R.L. Dawkins, F.T. Christiansen and P.H. Kay (1983) Disease associations with complotypes, supratypes and haplotypes. Immunol. Rev. 70 5.
74. F.T. Christiansen, R.L. Dawkins and G. Uko (1983) Complement allotyping in SLE: Association with C4A Null. Aust. N. Z. J. Med. 13 483.
75. P.J. Maddison, T.T. Provost and M. Reichlin (1981) Serologic findings in patients with ANA-negative SLE. Medicine (Baltimore) 60 87.
76. T.T. Provost, F.C. Arnett and M. Reichlin (1983) Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. Arthritis Rheum. 26 1279.
77. M.E. Kemp, J.P. Atkinson, V.M. Skames, R.P. Levine and D.D. Chaplin (1987) Deletion of C4A genes in patients with systemic lupus erythematosus. Arthritis Rheum. 30 1015-1022.
78. J.D. Reveille, F.C. Arnett and R.W. Wilson (1985) Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus. Immunogenetics 21 299.
79. K. Tokunaga, K. Imoto and T. Akaza (1985) Haplotype study on C4 polymorphism in Japanese: Association with MHC alleles, complotypes, and HLA-complement haplotypes. Immunogenetics 22 359.
80. P.F. Howard, M.C. Hochberg and W.B. Bias (1986) Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and Black Americans. Am. J. Med. 81 187.
81. B.R. Hawkins, K.L. Wong and R.W. Wong (1987) Strong association between the major histocompatibility complex and systemic lupus erythematosus in southern Chinese. J. Rheumatol. 14 1128.
82. J.R. Batchelor, A.H.L. Fielder and M.J. Walport (1987) Family study of the major histocompatibility complex in HLA DR3 negative patients with systemic lupus erythematosus. Clin. Exp. Immunol. 70 364.
83. J. Granados, I. Oliveras and H. Melin (1987) Further evidence of the role of complement genotypes in susceptibility to systemic lupus erythematosus (SLE) obtained from Mexican family studies. Arthritis Rheum. 30(Suppl.), 21.
84. A. Gougerot, D. Stoppa-Lyonnet and J.C. Poirier (1987) HLA markers and complotypes: Risk factors in systemic lupus erythematosus. Ann. Dermatol. Venereol. 114 329.
85. W.A. Wilson, M.C. Perez and P.E. Armatis (1988) Partial C4A deficiency is associated with susceptibility to systemic lupus erythematosus in Black Americans. Arthritis Rheum. 31 1171.
86. S.R. Dahlquist, G. Beckman and L. Beckman (1988) Serum protein markers in systemic lupus erythematosus. Hum. Hered. 38 44.
87. Y. Yukiyama, K. Tokunaga and F. Takeuchi (1988) Genetic polymorphism of complement in patients with systemic lupus erythematosus II. The fourth (C4) and the seventh (7) components of complement. Jpn. J. Rheumatol. 1 271.
88. X.-Z. Zhao, W.J. Zhang and Y.W. Tian (1989) Allotypic differences and frequencies of C4 null alleles (C4Q0) detected in patients with systemic lupus erythematosus (SLE). Chin. Sci. Bull. 34 237-240.
89. M.L. Olsen, R. Goldstein and F.C. Arnett (1989) C4A genedeletion and HLA associations in Black Americans with systemic lupus erythematosus. Immunogenetics 30 27.
90. K. Hartung, M.P. Baur, R. Coldewey, M. Fricke, J.R. Kalden, H.J. Lakomek, H.H. Peter, D. Schendel, P.M. Schneider, S.A. Seuchter, et al. (1992) Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus: Results of a multicenter study. J. Clin. Invest. 90 1346-1351.
91. R. Goldstein, F.C. Arnett and R.H. McLean (1988) Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus. Arthritis Rheum. 31 726.
92. K. Hartung, E. Albert, M. Baur, F. Coldewey, J.R. Kalden, H.J. Lakomek, H.H. Peter, D. Schendel, P.M. Schneider, S. Seuchter, W. Stangel and H. Deicher (1989) MHC haplotypes and complement C4 alleles in systemicllupus erythematosus: Results of a multicenter study. J. Clin. Invest. 90 1346.
93. K.E. Sullivan, N.A. Kim, D. Goldman and M.A. Petri (1999) C4A deficiency due to a 2bp insertion is increased in patients with systemic lupus erythematosus. J. Rheumatol. 26 2144-2147.
94. A. Gougerot, D. Stoppa-Lyonnet, J.C. Poirier, M. Schmid, M. Busson and A. Marcelli (1987) HLA markers and complotypes: Risk factors in systemic lupus erythematosus? Ann. Dermatol. Venereol. 114 329-334.
95. D. DeJuan, J.M. Martin-Villa, R. Gomez, J.L. Vicario, A. Corell, J. Martinez-Laso, D. Benmammar and A. Arnaiz-Villena (1993) Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility. Hum. Genet. 91 579.
96. D.G. Doherty, R. Ireland, A.G. Demaine, F. Wang, K. Veerapan, K.I. Welsh and D. Vergani (1992) Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese. Arthritis Rheum. 35 641.
97. G.H. Hong, H.Y. Kim and F. Takeuchi (1994) Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreams. J. Rheumatol. 21 442-447.
98. M. Yamada, A. Watanabe and A. Mimori (1990) Lack of gene deletion for complement C4: A deficiency in Japanese patients with systemic lupus erythematosus. J. Rheumatol. 17 1054.
99. Y. Fukumori, K. Yoshimura, S. Ohnoki, H. Yamaguchi, Y. Akagaki and S. Inai (1989) A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan. Int. Immunol. 1 85-89.
100. S. Inai, Y. Akagaki and T. Moriyama (1989) Inherited deficiencies of the late-acting complement components other than C9 found among healthy blood donors. Int. Arch. Allergy Appl. Immunol. 90 274-279.
101. T.C. Farries, K.L. Steuer-Knutzen and J.P. Atkinson (1990) Evolutionary implications of a new bypass activation pathway of the complement system. Immunol. Today 11 78-80.
102. Z. Fronek, L.A. Timmerman and C.A. Alper (1990) Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum. 33 1542.
103. M. Rudwaleit, M. Tikly, K. Gibson, K. Pile and P. Wordsworth (1995) HLA class II antigens associated with systemic lupus erythematosus in Black South Africants. Ann. Rheum. Dis. 54 678-680.
104. K.A. Davies, K. Erlendsson, H.L.C. Beynon, A.M. Peters, K. Steinsson, H. Valdimarsson and M.J. Walport (1993) Splenic uptake of immune complexes in man is complement-dependent. J. Immunol. 151 3866-3873.
105. S. Skarsvag (1995) The importance of C4A null genes in Norwegian patients with systemic lupus erythematosus. Scand. J. Immunol. 42 572.
106. V. Agnello (1986) Lupus diseases associated with hereditary and acquired deficiencies of complement. Springer Semin. Immunopathol. 9 161-178.
107. E. Sim, E.W. Gill and R.B. Sim (1984) Drugs that induce systemic lupus erythematosus inhibit complement component. Lancet 1 422.
108. C.A. Johnson, P. Densen, R.A. Wetsel, F.S. Cole, N.E. Goeken and H.R. Colten (1992) Molecular heterogeneity of C2 deficiency. N. Engl. J. Med. 326 871-874.
109. J.P. Atkinson (1992) Genetic susceptibility and class III complement genes. R.G. Lahita (Eds) Systemic Lupus Erythematosus New York: Churchill Livingstone 87-102.
110. L.A. Hebert and F.G. Cosio (1987) The erythrocyteimmune complex-glomerulonephritis connection in man. Kidney Int. 31 877-885.
111. J.A. Schifferli, Y.C. Ng, J.P. Paccaud and M.J. Walport (1989) The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Clin. Exp. Immunol. 75 329.
112. L.E. Kahl and J.P. Atkinson (1988) Autoimmune aspects of complement deficiency. Clin. Aspects Autoimmun. 2 8-20.
113. M.J. Walport and P.J. Lachmann (1988) Erythrocyte complementreceptor type 1, immune complexes, and the rheumatic diseases. Arthritis Rheum. 31 153-158.
114. P.R. Taylor, A. Carugati, V.A. Fadok, H.T. Cook, M. Andrews, M.C. Carroll, J.S. Savill, P.M. Henson, M. Botto and M.J. Walport (2000) A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 7 359-366.
115. J.S. Navratil, L.C. Korb and J.M. Ahearn (1999) Systemic lupus erythematosus and complement deficiency: Clues to a novel role for the classical complement pathway in the maintenance of immune tolerance. Immunopharmacology 42 47-52.
116. M. Botto (2001) Links between complement deficiency and apoptosis. Arthritis Res. 3 207-210.
117. J.A. Schifferli, G. Steiger and G. Hauptmann (1985) Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. J. Clin. Invest. 76 2127-2133.
118. J.A. Schifferli, G. Hauptmann and J.P. Paccaud (1987) Complement-mediated adherence of immune complexes to human erythrocytes: Differences in the requirements for C4A and C4B. FEBS Lett. 213 415.
119. I. Paul, V.M. Skanes and J. Mayden (1988) C4-mediated inhibition of immune precipitation and differences in inhibitory action of genetic variants, C4A3 and C4B1. Complement 5 110.
120. G. Sturfelt, A. Bengtsson, C. Klint, O. Nived, A. Sjoholm and L. Truedsson (2000) Novel roles of complement in systemic lupus erythematosus: Hypothesis for a pathogenetic vicious circle. J. Rheumatol. 27 661-663.
121. M. Salmon and C. Gordon (1999) The role of apoptosis in systemic lupus erythematatosus. Rheumatology (Oxford) 38 1177-1183.
122. C.M. Reilly and G.S. Gilkeson (2002) Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice. Immunol. Res. 25 143-153.
123. V.M. Holers (2000) Phenotypes of complement knockouts. Immunopharmacology 49 125-131.
124. H. Watanabe, G. Garnier, A. Circolo, R.A. Wetsel, P. Ruiz, V.M. Holers, S.A. Boackle, H.R. Colten and G.S. Gilkeson (2000) Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164 786-794.
125. Z. Chen, S.B. Koralov and G. Kelsoe (2000) Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 192 1339-1352.
126. S. Einav, O.O. Pozdnyakova, M. Ma and M.C. Carroll (2002) Complement C4 is protective for lupus disease independent of C3. J. Immunol. 168 1036-1041.
127. P.R. Taylor, J.T. Nash, E. Theodoridis, A.E. Bygrave, M.J. Walport and M. Botto (1998) A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J. Biol. Chem. 273 1699-1704.
128. M. Matsumoto, W. Fukuda, A. Circolo, J. Goellner, J. Strauss-Schoenberger, X. Wang, S. Fugita, T. Hidvegi, D.D. Chaplin and H.R. Colten (1997) Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. USA 94 8720-8725.
129. D.A. Mitchell, P.R. Taylor, H.T. Cook, J. Moss, A.E. Bygrave, M.J. Walport and M. Botto (1999) Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. J. Immunol. 162 5676-5679.
130. D.A. Mitchell, M.C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H.T. Cook, M. Botto and M.J. Walport (2002) C1q deficiency and autoimmunity: The effects of genetic background on disease expression. J. Immunol. 168 2538-2543.
131. M. Botto, C. Dell-Agnola, A.E. Bygrave, E.M. Thompson, H.T. Cook, F. Petry, M. Loos, P.P. Pandolfi and M.J. Walport (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet. 19 56-59.
132. L. Ellman, I. Green and F. Judge (1971) In vivo studies in C4-deficient guinea pigs. J. Exp. Med. 134 162.
133. E.C. Bottger, T. Hoffmann and U. Hadding (1985) Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. J. Immunol. 135 4100.
134. H.D. Ochs, J. Wedgwood and M.M. Frank (1983) The role of complement in induction of antibody responses. Clin. Exp. Immunol. 53 208.
135. G.D. Ross, W.J. Yount, M.J. Walport, J.B. Winfield, C.J. Parker, C.R. Fuller, R.P. Taylor, B.L. Myones and P.J. Lachmann (1985) Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J. Immunol. 135 2005-2014.
136. J. Duffy, M.D. Lidsky and J.T. Sharp (1976) Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore) 55 19.
137. D. Milich (2002) Influence of C4A deficiency on nonresponse to HBsAg vaccination: A new immune response gene. J. Hepatol. 37 396.
138. T. Hohler, B. Stradmann-Bellinghausen, R. Starke, R. Sanger, A. Victor, C. Rittner and P. Schneider (2002) C4A deficiency and nonresponse to hepatitis B vaccination. J. Hepatol. 37 387.
139. S.C. Ross and P. Densen (1984) Complement deficiency states and infection: Epidemiology, pathogenesis and consequences of Neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63 243-273.
140. J.P. Atkinson, J.L. Kaine, V.M. Holers and A.C. Chan (1986) Complement and the rheumatic diseases. G.D. Ross (Eds) Immunobiology of the Complement System: An Introduction for Research and Clinical Medicine Orlando: Academic Press 197-211.
141. G. Uko, F.T. Christiansen and R.L. Dawkins (1986) Serum C4 concentrations in the monitoring of systemic lupus erythematosus: Requirements for C4 allotyping. Rheumatol. Int. 6 111-114.
142. W.J. Zhang, P.H. Kay and T.J. Cobain (1988) C4 allotyping on plasma or serum: Application to routine laboratories. Hum. Immunol. 21 165.
143. J. Kramer, E. Gyodi and G. Fust (1989) Usefulness of densitometry in typing of human complement component C4. Immunogenetics 29 121.
144. E. Sim and S.J. Cross (1986) Phenotyping of human complement component C4, a class-III HLA antigen. Biochem. J. 239 763.
145. D. Hourcade, D.R. Miesner, C. Bee, W. Zeldes and J.P. Atkinson (1990) Duplication and divergence of the aminoterminal coding region of the complement receptor 1 (CR1) gene. J. Biol. Chem. 265 974-980.
146. J. Chrispeels, S. Bank, C. Rittner and D. Bitter-Suermann (1989) Sandwich enzyme-linked immunosorbent assays for the quantification of the C4 isotypes, (C4A and C4B) in human plasma. J. Immunol. Methods 125 5.
147. L.-M. Hsiung, D.W. Mason and A. Dodds (1987) A monoclonal antibody which can distinguish between the two isotypes of human C4. Mol. Immunol. 24 91.
148. R.L. Dawkins, K. Tokunaga and G. Saueracker (1989) MHC gene arrangements on disease associated supra-types revealed by pulsed field gel electrophoresis. B. Dupont (Eds) Immunobiology of HLA New York: Springer Verlag
149. A. Palsdottir, R. Fossdal and A. Arnason (1987) Heterogeneity of human C4 gene size: A large intron (6.5 kb) is present in all C4A genes and some C4B genes. Immunogenetics 25 299.
150. C.Y. Yu and R.D. Campbell (1987) Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: Application to the study of C4 null alleles. Immunogenetics 25 383.
151. G. Mauff, B. Luther, P.M. Schneider, C. Rittner, B. Stradmann-Bellinghausen, R. Dawkins and J.M. Moulds (1998) Reference typing report for complement component C4. Exp. Clin. Immunogenet. 15 249-260.
152. M.K. Liszewski, L.E. Kahl and J.P. Atkinson (1989) The functional role of complement genes in SLE and Sjogren's syndrome. Curr. Opin. Rheumatol. 1 347-352.
153. N.E. Hughes-Jones (1986) The classical pathway. G.D. Ross (Eds) Immunobiology of the Complement System San Diego: Academic Press 21.
154. M.K. Liszewski and J.P. Atkinson (1991) The role of complement in autoimmunity. M.R. Reichlin, P. Bigazzi (Eds) Systemic Autoimmunity New York: Dekker 13-37.
155. M.S. Kruskall, C.A. Alper and E.J. Yunis (1990) HLA-homozygous donors and transfusion-associated graftversus-host disease. N. Engl. J. Med. 322 1005.
156. D. Glass, D. Raum, D. Gibson, J.S. Stillman and P.H. Schur (1976) Inherited defiency of the second component of complement: Rheumatic disease associations. J. Clin. Invest. 58 853-861.
157. P.H. Schur (1982) Complement and lupus erythematosus. Arthritis Rheum. 25 793-798.
158. K.E. Sullivan, M.A. Petri, B.J. Schmeckpeper, R.H. McLean and J.A. Winkelstein (1994) Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus. J. Rheumatol. 21 1128-1133.
159. H. Dunkley, P.A. Gatenby and B.R. Hawkins (1987) Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J. Immunogenet. 14 209.
160. E.J. Davies, M.C. Hillarby, R.G. Cooper, et al. (1993) HLA-DQ, DR and complement C4 variance in systemic lupus erythematosus. Br. J. Rheumatol. 32 870.
161. P.H. Schur, D. Marcus-Bagley, Z. Awdeh, E.J. Yunic and C.A. Alper (1990) The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. Arthritis Rheum. 33 985.
162. J. Granados, G. Vargas-Alarcon, F. Andrade, et al. (1996) The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans. Lupus 5 194.
163. H. Dunkley, P.A. Gatenby and B.R. Hawkins (1987) Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J. Immunogenet. 14 209.